Vinken M - Search Results

1

Yanguas SC, Cogliati B, Willebrords J, Maes M, Colle I, van den Bossche B, de Oliveira CPMS, Andraus W, Alves VAF, Leclercq I, Vinken M. Yanguas SC, et al. Among authors: vinken m. Arch Toxicol. 2016 May;90(5):1025-1048. doi: 10.1007/s00204-015-1543-4. Epub 2015 Jun 6. Arch Toxicol. 2016. PMID: 26047667 Free PMC article. Review.

2

Characterization of spontaneous cell death in monolayer cultures of primary hepatocytes.

Vinken M, Decrock E, Doktorova T, Ramboer E, De Vuyst E, Vanhaecke T, Leybaert L, Rogiers V. Vinken M, et al. Arch Toxicol. 2011 Dec;85(12):1589-96. doi: 10.1007/s00204-011-0703-4. Epub 2011 Apr 11. Arch Toxicol. 2011. PMID: 21479951

3

Screening of repeated dose toxicity data present in SCC(NF)P/SCCS safety evaluations of cosmetic ingredients.

Vinken M, Pauwels M, Ates G, Vivier M, Vanhaecke T, Rogiers V. Vinken M, et al. Arch Toxicol. 2012 Mar;86(3):405-12. doi: 10.1007/s00204-011-0769-z. Epub 2011 Oct 29. Arch Toxicol. 2012. PMID: 22038139

4

Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.

Doktorova TY, Ellinger-Ziegelbauer H, Vinken M, Vanhaecke T, van Delft J, Kleinjans J, Ahr HJ, Rogiers V. Doktorova TY, et al. Among authors: vinken m. Arch Toxicol. 2012 Sep;86(9):1399-411. doi: 10.1007/s00204-012-0847-x. Epub 2012 Apr 8. Arch Toxicol. 2012. PMID: 22484513

5

Modifications in connexin expression in liver development and cancer.

Vinken M, De Kock J, Oliveira AG, Menezes GB, Cogliati B, Dagli ML, Vanhaecke T, Rogiers V. Vinken M, et al. Cell Commun Adhes. 2012 Aug;19(3-4):55-62. doi: 10.3109/15419061.2012.712576. Epub 2012 Sep 5. Cell Commun Adhes. 2012. PMID: 22950570 Review.

6

Comparison of genotoxicant-modified transcriptomic responses in conventional and epigenetically stabilized primary rat hepatocytes with in vivo rat liver data.

Doktorova TY, Ellinger-Ziegelbauer H, Vinken M, Vanhaecke T, van Delft J, Kleinjans J, Ahr HJ, Rogiers V. Doktorova TY, et al. Among authors: vinken m. Arch Toxicol. 2012 Nov;86(11):1703-15. doi: 10.1007/s00204-012-0946-8. Epub 2012 Sep 28. Arch Toxicol. 2012. PMID: 23052194

7

Proteomic and metabolomic responses to connexin43 silencing in primary hepatocyte cultures.

Vinken M, Maes M, Cavill R, Valkenborg D, Ellis JK, Decrock E, Leybaert L, Staes A, Gevaert K, Oliveira AG, Menezes GB, Cogliati B, Dagli ML, Ebbels TM, Witters E, Keun HC, Vanhaecke T, Rogiers V. Vinken M, et al. Arch Toxicol. 2013 May;87(5):883-94. doi: 10.1007/s00204-012-0994-0. Epub 2012 Dec 7. Arch Toxicol. 2013. PMID: 23224291

8

Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies.

Fraczek J, Bolleyn J, Vanhaecke T, Rogiers V, Vinken M. Fraczek J, et al. Among authors: vinken m. Arch Toxicol. 2013 Apr;87(4):577-610. doi: 10.1007/s00204-012-0983-3. Epub 2012 Dec 15. Arch Toxicol. 2013. PMID: 23242478 Review.

9

Purinergic signalling during sterile liver injury.

Oliveira AG, Marques PE, Amaral SS, Quintão JL, Cogliati B, Dagli ML, Rogiers V, Vanhaecke T, Vinken M, Menezes GB. Oliveira AG, et al. Among authors: vinken m. Liver Int. 2013 Mar;33(3):353-61. doi: 10.1111/liv.12109. Liver Int. 2013. PMID: 23402607 Review.

10

Drug-induced liver injury: mechanisms, types and biomarkers.

Vinken M, Maes M, Vanhaecke T, Rogiers V. Vinken M, et al. Curr Med Chem. 2013;20(24):3011-21. doi: 10.2174/0929867311320240006. Curr Med Chem. 2013. PMID: 23746274

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

253 results

Search Page